Peterson Kristine — SEC insider filings

SEC reporting owner CIK 1508596. 26 insider filings on record with FilingPulse; latest filed 2026-10-20.

Transaction summary — filings shown

Covers all 26 filings on record, filed 2021-02-22 to 2026-10-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ImmunoGen, Inc. (IMGN)Director6—1 leg · 20,000 sh · $578,00023
Paratek Pharmaceuticals, Inc. (PRTK)Director4——12
ENANTA PHARMACEUTICALS INC (ENTA)Director6——6
AMARIN CORP PLC\UK (AMRN)Director2——4
ArriVent BioPharma, Inc. (AVBP)Director3——3
Immunocore Holdings plc (IMCR)Director3——3
Mineralys Therapeutics, Inc. (MLYS)Director2——2

Insider filings — Peterson Kristine

FiledFormIssuerReported transactionsSource
2026-10-203Mineralys Therapeutics, Inc. (MLYS)Holdings only — no transactions reportedEDGAR
2026-10-204Mineralys Therapeutics, Inc. (MLYS)Grant/award (A): 12,400 @ $0 · Grant/award (A): 16,600 (derivative) @ $0EDGAR
2026-06-224ArriVent BioPharma, Inc. (AVBP)Grant/award (A): 13,562 (derivative) @ $0EDGAR
2026-05-284Immunocore Holdings plc (IMCR)Grant/award (A): 27,492 (derivative) @ $0EDGAR
2026-03-134ENANTA PHARMACEUTICALS INC (ENTA)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2025-06-204ArriVent BioPharma, Inc. (AVBP)Grant/award (A): 15,502 (derivative) @ $0EDGAR
2025-05-194Immunocore Holdings plc (IMCR)Grant/award (A): 26,198 (derivative) @ $0EDGAR
2025-03-144ENANTA PHARMACEUTICALS INC (ENTA)Grant/award (A): 15,700 (derivative) @ $0EDGAR
2024-05-284Immunocore Holdings plc (IMCR)Grant/award (A): 14,534 (derivative) @ $0EDGAR
2024-04-234ArriVent BioPharma, Inc. (AVBP)Grant/award (A): 28,587 (derivative) @ $0EDGAR
2024-03-084ENANTA PHARMACEUTICALS INC (ENTA)Grant/award (A): 15,700 (derivative) @ $0EDGAR
2024-02-124ImmunoGen, Inc. (IMGN)Disposition to issuer (D): 13,090 (derivative) · Disposition to issuer (D): 74,954 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 18,000 (derivative) · Disposition to issuer (D): 18,000 (derivative) · +4 moreEDGAR
2023-12-054ImmunoGen, Inc. (IMGN)Option exercise (M): 10,000 @ $10.10 · Option exercise (M): 10,000 @ $13.07 · Sale (S): 20,000 @ $28.90 · Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2023-09-214Paratek Pharmaceuticals, Inc. (PRTK)Disposition to issuer (D): 59,000 · Disposition to issuer (D): 20,000 · Disposition to issuer (D): 7,000 (derivative) · Disposition to issuer (D): 7,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · +2 moreEDGAR
2023-09-144ImmunoGen, Inc. (IMGN)Option exercise (M): 10,000 @ $14.70 · Option exercise (M): 10,000 @ $16.08 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2023-06-164ImmunoGen, Inc. (IMGN)Grant/award (A): 13,090 (derivative) @ $0 · Grant/award (A): 19,597 (derivative) @ $0EDGAR
2023-03-064ENANTA PHARMACEUTICALS INC (ENTA)Grant/award (A): 10,800 (derivative) @ $0EDGAR
2023-02-094Paratek Pharmaceuticals, Inc. (PRTK)Grant/award (A): 20,000 @ $0EDGAR
2022-06-294AMARIN CORP PLC\UK (AMRN)Grant/award (A): 115,919 (derivative) @ $0 · Grant/award (A): 93,750 (derivative) @ $0EDGAR
2022-06-174ImmunoGen, Inc. (IMGN)Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 44,000 (derivative) @ $3.37EDGAR
2022-03-074ENANTA PHARMACEUTICALS INC (ENTA)Grant/award (A): 7,500 (derivative) @ $0EDGAR
2022-02-184Paratek Pharmaceuticals, Inc. (PRTK)Grant/award (A): 20,000 @ $0EDGAR
2021-06-174ImmunoGen, Inc. (IMGN)Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 44,000 (derivative) @ $6.77EDGAR
2021-06-164AMARIN CORP PLC\UK (AMRN)Grant/award (A): 45,953 (derivative) @ $0 · Grant/award (A): 36,000 (derivative) @ $0EDGAR
2021-03-044ENANTA PHARMACEUTICALS INC (ENTA)Grant/award (A): 7,500 (derivative) @ $0EDGAR
2021-02-224Paratek Pharmaceuticals, Inc. (PRTK)Grant/award (A): 9,000 @ $0 · Grant/award (A): 7,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-02-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1508596 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs